An IOM report makes recommendations that aim to ensure that progress in omics-based test development is grounded in sound scientific evidence and is reproducible, resulting in improved health care and continued public trust in research. Another new IOM roundtable workshop report discussed the differences in evidence required for clinical use, regulatory oversight, guideline inclusion, coverage, and reimbursement of genomic diagnostic tests and focused …
Post Author: Michael P. Douglas and W. David Dotson, PhD
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.